📣 VC round data is live. Check it out!
- Public Comps
- Huaxia Eye Hospital Group
Huaxia Eye Hospital Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Huaxia Eye Hospital Group and similar public comparables like Dr. Soliman Abdul Kader, Acadia Healthcare, Select Medical, MLP Sağlık and more.
Huaxia Eye Hospital Group Overview
About Huaxia Eye Hospital Group
Huaxia Eye Hospital Group Co Ltd is a ophthalmic medical chain group in China. It offers ophthalmology specialist medical services.
Founded
2004
HQ

Employees
N/A
Website
Sectors
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialHuaxia Eye Hospital Group Financials
Huaxia Eye Hospital Group reported last 12-month revenue of $629M and EBITDA of $135M.
In the same LTM period, Huaxia Eye Hospital Group generated $273M in gross profit, $135M in EBITDA, and $69M in net income.
Revenue (LTM)
Huaxia Eye Hospital Group P&L
In the most recent fiscal year, Huaxia Eye Hospital Group reported revenue of $612M and EBITDA of $141M.
Huaxia Eye Hospital Group is profitable as of last fiscal year, with gross margin of 43%, EBITDA margin of 23%, and net margin of 11%.
Financial data powered by Morningstar, Inc.
Huaxia Eye Hospital Group Stock Performance
Huaxia Eye Hospital Group has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Huaxia Eye Hospital Group's stock price is $2.60.
Huaxia Eye Hospital Group share price increased by 0.5% in the last 30 days, and decreased by 6.7% in the last year.
Huaxia Eye Hospital Group has an EPS (earnings per share) of $0.08.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.5% | 0.5% | 5.1% | -6.7% | $0.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHuaxia Eye Hospital Group Valuation Multiples
Huaxia Eye Hospital Group trades at 2.8x EV/Revenue multiple, and 13.1x EV/EBITDA.
EV / Revenue (LTM)
Huaxia Eye Hospital Group Financial Valuation Multiples
As of June 2, 2026, Huaxia Eye Hospital Group has market cap of $2B and EV of $2B.
Huaxia Eye Hospital Group has a P/E ratio of 31.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Huaxia Eye Hospital Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Huaxia Eye Hospital Group Margins & Growth Rates
Huaxia Eye Hospital Group grew revenue by 8% but EBITDA decreased by 4% in the last fiscal year.
In the most recent fiscal year, Huaxia Eye Hospital Group reported gross margin of 43%, EBITDA margin of 23%, and net margin of 11%.
Huaxia Eye Hospital Group Margins
Huaxia Eye Hospital Group Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Huaxia Eye Hospital Group Operational KPIs
Huaxia Eye Hospital Group's Rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Huaxia Eye Hospital Group's Rule of X is 41% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Huaxia Eye Hospital Group Competitors
Huaxia Eye Hospital Group competitors include Dr. Soliman Abdul Kader, Acadia Healthcare, Select Medical, MLP Sağlık, Topchoice Medical, Guardian Pharmacy Service, Astrana Health, Akdital, Draegerwerk and Pediatrix.
Most Huaxia Eye Hospital Group public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.3x | 2.8x | 16.6x | 17.0x | |||
| 1.4x | 1.4x | 7.6x | 7.7x | |||
| 0.9x | 0.9x | 9.4x | 9.9x | |||
| 1.7x | 1.5x | 5.3x | 5.5x | |||
| 5.9x | 5.6x | 18.3x | 17.8x | |||
| 1.7x | 1.7x | 21.3x | 20.6x | |||
| 0.8x | 0.7x | 12.0x | 10.6x | |||
| 4.4x | 3.7x | 14.8x | 13.3x | |||
This data is available for Pro users. Sign up to see all Huaxia Eye Hospital Group competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Huaxia Eye Hospital Group
| When was Huaxia Eye Hospital Group founded? | Huaxia Eye Hospital Group was founded in 2004. |
| Where is Huaxia Eye Hospital Group headquartered? | Huaxia Eye Hospital Group is headquartered in China. |
| Is Huaxia Eye Hospital Group publicly listed? | Yes, Huaxia Eye Hospital Group is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group trades under 301267 ticker. |
| When did Huaxia Eye Hospital Group go public? | Huaxia Eye Hospital Group went public in 2022. |
| Who are competitors of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group main competitors include Dr. Soliman Abdul Kader, Acadia Healthcare, Select Medical, MLP Sağlık, Topchoice Medical, Guardian Pharmacy Service, Astrana Health, Akdital, Draegerwerk, Pediatrix. |
| What is the current market cap of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group's current market cap is $2B. |
| What is the current revenue of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group's last 12 months revenue is $629M. |
| What is the current revenue growth of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Huaxia Eye Hospital Group? | Current revenue multiple of Huaxia Eye Hospital Group is 2.8x. |
| What is the current EBITDA of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group's last 12 months EBITDA is $135M. |
| What is Huaxia Eye Hospital Group's EBITDA margin? | Huaxia Eye Hospital Group's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Huaxia Eye Hospital Group? | Current EBITDA multiple of Huaxia Eye Hospital Group is 13.1x. |
| How many companies Huaxia Eye Hospital Group has acquired to date? | Huaxia Eye Hospital Group hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Huaxia Eye Hospital Group has invested to date? | Huaxia Eye Hospital Group hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Huaxia Eye Hospital Group
Lists including Huaxia Eye Hospital Group
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.